학술논문
First-in-Human Study of the Reversible BTK Inhibitor Nemtabrutinib in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia and B-Cell Non–Hodgkin Lymphoma
Document Type
Article
Author
Source
In: Cancer Discovery . (Cancer Discovery, January 2024, 14(1):66-75)
Subject
Language
English
ISSN
21598290
21598274
21598274